Trial intelligence / Profile preview

Ultrasound-guided TAP block with ropivacaine for pain control after elective caesarean section

ACTRN12607000389404Phase 3Not yet recruiting

Sponsor
St Vincent's Hospital
Start
Jul 2007
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
01

Overview

Phase 3, randomised trial of ropivacaine in postoperative pain (2 arms), sponsored by St Vincent's Hospital. Primary endpoint: Morphine requirement by patient. Planned start Jul 2007; status: not yet recruiting.

02

Drugs

ropivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on ACTRN12607000389404.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12607000389404.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call